340 related articles for article (PubMed ID: 25761664)
41. Circulating tumor cells in early breast cancer: A connection with vascular invasion.
Maltoni R; Fici P; Amadori D; Gallerani G; Cocchi C; Zoli M; Rocca A; Cecconetto L; Folli S; Scarpi E; Serra P; Fabbri F
Cancer Lett; 2015 Oct; 367(1):43-8. PubMed ID: 26184997
[TBL] [Abstract][Full Text] [Related]
42. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
43. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
[TBL] [Abstract][Full Text] [Related]
44. Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.
Mitchell MJ; Castellanos CA; King MR
J Nanomater; 2012; 2012():. PubMed ID: 25152752
[TBL] [Abstract][Full Text] [Related]
45. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
46. Comparative study on antibody immobilization strategies for efficient circulating tumor cell capture.
Ates HC; Ozgur E; Kulah H
Biointerphases; 2018 Mar; 13(2):021001. PubMed ID: 29571263
[TBL] [Abstract][Full Text] [Related]
47. Biocompatible TiO2 nanoparticle-based cell immunoassay for circulating tumor cells capture and identification from cancer patients.
He R; Zhao L; Liu Y; Zhang N; Cheng B; He Z; Cai B; Li S; Liu W; Guo S; Chen Y; Xiong B; Zhao XZ
Biomed Microdevices; 2013 Aug; 15(4):617-626. PubMed ID: 23780622
[TBL] [Abstract][Full Text] [Related]
48. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
49. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
[TBL] [Abstract][Full Text] [Related]
50. Albumin-coated monodisperse magnetic poly(glycidyl methacrylate) microspheres with immobilized antibodies: application to the capture of epithelial cancer cells.
Horák D; Svobodová Z; Autebert J; Coudert B; Plichta Z; Královec K; Bílková Z; Viovy JL
J Biomed Mater Res A; 2013 Jan; 101(1):23-32. PubMed ID: 22767416
[TBL] [Abstract][Full Text] [Related]
51. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
52. Biomimetic immunomagnetic gold hybrid nanoparticles coupled with inductively coupled plasma mass spectrometry for the detection of circulating tumor cells.
Chang ZM; Zhou H; Yang C; Zhang R; You Q; Yan R; Li L; Ge M; Tang Y; Dong WF; Wang Z
J Mater Chem B; 2020 Jun; 8(23):5019-5025. PubMed ID: 32393955
[TBL] [Abstract][Full Text] [Related]
53. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.
Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH
ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336
[TBL] [Abstract][Full Text] [Related]
54. Channel surface patterning of alternating biomimetic protein combinations for enhanced microfluidic tumor cell isolation.
Launiere C; Gaskill M; Czaplewski G; Myung JH; Hong S; Eddington DT
Anal Chem; 2012 May; 84(9):4022-8. PubMed ID: 22482510
[TBL] [Abstract][Full Text] [Related]
55. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells.
Deng Y; Zhang Y; Sun S; Wang Z; Wang M; Yu B; Czajkowsky DM; Liu B; Li Y; Wei W; Shi Q
Sci Rep; 2014 Dec; 4():7499. PubMed ID: 25511131
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles.
Lee HJ; Cho HY; Oh JH; Namkoong K; Lee JG; Park JM; Lee SS; Huh N; Choi JW
Biosens Bioelectron; 2013 Sep; 47():508-14. PubMed ID: 23628845
[TBL] [Abstract][Full Text] [Related]
57. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
[TBL] [Abstract][Full Text] [Related]
59. Technologies for detection of circulating tumor cells: facts and vision.
Alix-Panabières C; Pantel K
Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
[TBL] [Abstract][Full Text] [Related]
60. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
